TY - JOUR T1 - Case of relapsing sulfasalazine-induced hypersensitivity syndrome upon re-exposure JF - BMJ Case Reports JO - BMJ Case Reports DO - 10.1136/bcr-2020-235803 VL - 13 IS - 9 SP - e235803 AU - Jason Winward AU - Laurel Lyckholm AU - Samuel M Brown AU - Mohamad Mokadem Y1 - 2020/09/01 UR - http://casereports.bmj.com/content/13/9/e235803.abstract N2 - Sulfasalazine-induced hypersensitivity syndrome (SIHS) is a serious systemic delayed adverse drug reaction that is associated with significant morbidity and mortality. Here, we report the first case, to our knowledge, of a patient with previously unidentified SIHS who developed a significantly more rapid and extreme recurrence on re-exposure to sulfasalazine. The patient is a 58-year-old woman with asymptomatic Crohn’s disease who, 10 days after initiating sulfasalazine, developed fevers, diffuse rash, pancytopenia, hypotension and hepatitis without a definitive source of infection. Sixteen days after her first hospitalisation, she was restarted on sulfasalazine and was readmitted within 10 hours with a similar but more serious presentation, requiring vasopressors. She did recover completely without any further recurrence to date, after definitively discontinuing sulfasalazine. This case demonstrates the importance of recognising SIHS early in patients to prevent re-exposure to sulfasalazine and to ensure timely initiation of appropriate treatment. ER -